Major depressive disorder clinical trials

What Is Actinic Keratosis?

Actinic keratosis (AK), also known as solar keratosis, is a common precancerous skin condition caused by years of sun exposure. It typically appears as small, rough, scaly patches on skin that's seen a lot of sun over time, most often the face, scalp, ears, and hands. These patches can be pink, red, or skin-colored, and while many stay small, some can thicken or grow if left untreated. Left unaddressed, a small percentage of AK lesions can progress into squamous cell carcinoma, a type of skin cancer, which is why early detection and treatment matter.

Current treatment options for actinic keratosis include topical medications, cryotherapy, and light-based therapies, but not everyone responds the same way, and lesions can return even after treatment. Actinic Keratosis clinical trials are exploring new treatment approaches that may help clear existing lesions and reduce the chance of recurrence for people who haven't found lasting results with the options already available.

Enroll Now!

Major Depressive Disorder

Advancing Mental Health Care Through Major Depressive Disorder Clinical Trials

Living with major depressive disorder (MDD) can make everyday life challenging, even with ongoing treatment. This major depressive disorder clinical trial is designed to evaluate investigational treatment and better understand the safety, effectiveness, and impact on symptoms in adults living with MDD. Participants will receive study-related care, attend scheduled visits with the research team, and be monitored throughout the study to assess their progress and overall well-being.

Taking part in a Major Depression Research Study may provide access to investigational treatment options and study-related care at no cost. If you qualify, you may be eligible to enroll in Major Depressive Disorder Clinical Trial in Indiana and contribute to research that may help improve future treatment options for people living with MDD.

Age
18 Years to 65 Years

Location:
Indiana

Status:
Recruiting

Condition
Major Depressive Disorder

What to Expect When You Join Major Depressive Disorder Clinical Trials

In these major depressive disorder clinical trials, participants can expect a structured and closely monitored research process. After a screening to determine eligibility, qualified participants will receive the study treatment assigned by the trial design and attend regular visits for mental health assessments, safety monitoring, and discussions with the research team.

By participating in one of the MDD Clinical Trials in Indiana, you contribute to a Major Depression Research Study that may help improve future treatment options for people living with MDD.

Frequently Asked
Questions


  • Adults between 18 and 65 years of age who have been diagnosed with major depressive disorder and meet the study requirements may qualify for MDD Clinical Trials in Indiana.

  • Eligible participants will complete a screening to determine eligibility, attend scheduled study visits, receive the study treatment assigned by the trial design, and undergo regular mental health assessments and safety monitoring.

  • Participants may receive study-related care and regular monitoring while contributing to research that could improve future treatment options for major depressive disorder.